Diagnostics
Findings from Spain, India and Belgium describe new data in diagnostics research
Published in TB and Outbreaks Week, May 2nd, 2006
Study 1: A mycobacteriophage-based assay rapidly assesses Mycobacterium tuberculosis susceptibility to isoniazid.
"We standardized and assessed the performance of an in-house microtiter assay for determining the susceptibilities of Mycobacterium tuberculosis clinical isolates to isoniazid based on mycobacteriophage amplification technology.
"Seventy isolates (43 resistant and 27 sensitive according to the BACTEC 460 radiometric method and MIC determination) were studied. The isoniazid resistance molecular mechanism was previously...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Drug Resistance
Corynebacterium striatum is an emerging multidrug-resistant pathogen in hospitalized patients - Infectious Diseases
Clostridium difficile-associated disease is an emerging threat to patient safety - SARS Outbreak
Hospital precautions during major acute SARS outbreak are outlined - Tuberculosis
Large tuberculosis outbreak occurred in private-home family child care center - Anthrax Antitoxin
Anthrax toxin neutralized by chimpanzee monoclonal antibodies against protective antigen - Antituberculosis Therapy Pharmacogenomics
NAT2 genotypes have a great impact on NAT 2 metabolism capacity in tuberculosis patients - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
